The Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) for serious mental illness in community mental health part 2: study protocol for a hybrid type 2 effectiveness-implementation cluster-randomized trial using train-the-trainer
DiscussionThis trial has potential to (a) inform the process of embedding local trainers and supervisors to expand delivery of a promising transdiagnostic treatment for sleep and circadian dysfunction, (b) add to the growing body of TTT literature by evaluating TTT outcomes with a novel treatment and population, and (c) advance our unders tanding of providers’ perceptions of EBPT “fit” across TTT generations.Trial registrationClinicalTrials.gov identifierNCT05805657. Registered on April 10, 2023. (Source: Trials)
Source: Trials - August 7, 2023 Category: Research Source Type: clinical trials
LSD-Perceptual-Choice-Study
Condition: LSD Reaction Interventions: Drug: LSD 10 μg; Drug: LSD 20 μg; Drug: Placebo Sponsors: University Hospital, Basel, Switzerland; University of Basel; University Psychiatric Clinics Basel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials
